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Abstract. 
 
We have identiﬁed and puriﬁed six subforms 
of peroxisomes, designated P1 to P6, from the yeast, 
 
Yarrowia lipolytica
 
. An analysis of trafﬁcking of peroxi-
somal proteins in vivo suggests the existence of a multi-
step peroxisome assembly pathway in 
 
Y
 
.
 
 lipolytica
 
. This 
pathway operates by conversion of peroxisomal sub-
 
forms in the direction P1
 
, 
 
P2
 
®
 
P3
 
®
 
P4
 
®
 
P5
 
®
 
P6 and in-
volves the import of various peroxisomal proteins into 
distinct vesicular intermediates. We have also reconsti-
tuted in vitro the fusion of the earliest intermediates in 
the pathway, small peroxisomal vesicles P1 and P2. 
Their fusion leads to the formation of a larger and more 
dense peroxisomal vesicle, P3. Fusion of P1 and P2 in 
vitro requires cytosol and ATP hydrolysis and is inhib-
ited by antibodies to two membrane-associated ATP-
ases of the AAA family, Pex1p and Pex6p. We provide 
evidence that the fusion in vitro of P1 and P2 peroxi-
somes reconstructs an actual early step in the peroxi-
some assembly pathway operating in vivo in 
 
Y
 
.
 
 lipo-
lytica
 
.
Key words: microbody • peroxisomal protein import 
• biogenesis • membrane fusion • in vitro reconsti-
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Introduction
 
The dynamic balance between fission and fusion of or-
ganelle membranes regulates organelle assembly and in-
heritance (Rothman and Warren, 1994; Warren and Wick-
ner, 1996). To characterize the machinery of membrane
fusion, homotypic (self) fusion reactions for different or-
ganelles have been reconstituted in vitro (Denesvre and
Malhotra, 1996; Warren and Wickner, 1996). Compara-
tive analyses of homotypic membrane fusion and of het-
erotypic (vectorial) vesicle-to-organelle membrane fusion
have revealed wide variation in the spectra, topology, and
regulation of components mediating membrane fusion.
Most heterotypic fusion reactions in the secretory path-
way depend on the cytosolic factors 
 
N
 
-ethylmaleimide-
sensitive factor (NSF)
 
1
 
 and soluble NSF attachment pro-
teins (SNAPs; Rothman, 1994; Pfeffer, 1996). Heterotypic
fusion of secretory vesicles to their target membranes is
initiated by binding of SNAP receptors (SNAREs), which
are vesicle- and target-specific integral membrane proteins
 
(v-SNAREs and t-SNAREs, respectively; Rothman, 1994).
Recruitment of NSF and SNAPs to the complex formed
by v- and t-SNAREs yields the SNARE complex (Roth-
man, 1994). According to the SNARE hypothesis (Roth-
man, 1994), ATP hydrolysis by NSF causes disassembly of
the SNARE complex and drives heterotypic membrane
fusion. Recently, it has been reported that NSF and
SNAPs may act at an ATP-dependent perfusion step
rather than in heterotypic membrane fusion itself (Cham-
berlain et al., 1995; Banerjee et al., 1996; Otto et al., 1997;
Weber et al., 1998).
Homotypic fusion of yeast vacuoles requires Sec18p
(NSF) and Sec17p (the yeast 
 
a
 
-SNAP homologue; Haas
and Wickner, 1996). ATP hydrolysis by Sec18p drives
Sec17p release, disassembly of unproductive interactions
between v- and t-SNAREs on the same membrane, and
activation of t-SNAREs (Nichols et al., 1997; Ungermann
et al., 1998; Ungermann and Wickner, 1998). All these re-
arrangements occur at a vacuole priming step that pre-
cedes docking and fusion steps. Homotypic fusion of ER
membranes in yeast is Sec18p- and Sec17p-independent
(Latterich and Schekman, 1994) and is instead mediated
by Cdc48p, another NSF-like AAA family ATPase (Lat-
terich et al., 1995; Patel and Latterich, 1998). Reassembly
of Golgi cisternae from drug-induced and postmitotic frag-
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ments is mediated by NSF and the AAA family ATPase,
p97/VCP (Acharya et al., 1995; Rabouille et al., 1995).
Recent findings have pointed to the possibility of mem-
brane fusion acting in the assembly of peroxisomes. Two
proteins essential for peroxisome biogenesis, the peroxins
Pex1p and Pex6p, are ATPases of the AAA family (Erd-
mann et al., 1991; Faber et al., 1998; Titorenko and Rachu-
binski, 1998), members of which are required for all
known homotypic and heterotypic membrane fusions (Pa-
tel and Latterich, 1998). Deficiency in Pex1p and Pex6p
results in the accumulation of small peroxisomal vesicles
in the yeasts, 
 
Pichia pastoris
 
 (Spong and Subramani, 1993;
Heyman et al., 1994), 
 
Saccharomyces cerevisiae
 
 (Purdue
and Lazarow, 1995), and 
 
Yarrowia lipolytica
 
 (Titorenko and
Rachubinski, 1998), and in CHO (Tamura et al., 1998) and
human cells (Geisbrecht et al., 1998; Tamura et al., 1998),
suggesting a defect in vesicle fusion during peroxisome
assembly (Acharya et al., 1995; Faber et al., 1998; Su-
bramani, 1998). In 
 
P
 
.
 
 pastoris
 
, Pex1p and Pex6p them-
selves have been shown to be associated with small peroxi-
somal vesicles that are distinct from mature peroxisomes
(Faber et al., 1998). These vesicles have been proposed to
undergo successive rounds of fusion to generate larger
vesicles, which in turn could assemble the import machin-
eries for peroxisomal membrane and matrix proteins, im-
port these proteins from the cytosol, and eventually ma-
ture into large, functional peroxisomes (Subramani, 1996;
Erdmann et al., 1997; Faber et al., 1998). Such a model
predicts that peroxisome maturation might be a multistage
process encompassing several consecutive steps and in-
volving the import of various peroxisomal proteins into
distinct intermediates. Evidence in support of this model
comes from the demonstration that under certain condi-
tions, the import of a subset of peroxisomal membrane
proteins into early peroxisomal precursors might precede,
and indeed be required for, the import of matrix proteins
(South and Gould, 1999). These results satisfactorily ex-
plain numerous observations on the heterogeneity of
mammalian and yeast peroxisomes in terms of their buoy-
ant densities, protein compositions and import competen-
cies (Heinemann and Just, 1992; Lüers et al., 1993; van Ro-
ermund et al., 1995; Wilcke et al., 1995; van der Klei and
Veenhuis, 1996). It should be noted, however, that small
peroxisomal vesicles, the postulated intermediates in the
peroxisome assembly process, have not yet been identi-
fied, purified, or characterized. Furthermore, it remains
unclear whether peroxisomal vesicles can actually fuse
with one another, what type of peroxisome could be
formed by fusion, and what might be the requirements of
the fusion process itself, particularly in regards to the ATP-
ases, Pex1p and Pex6p.
Here we report the identification and purification of six
subforms of peroxisomes from 
 
Y
 
.
 
 lipolytica
 
. We show that
these subforms are organized into a multistep peroxisome
assembly pathway. This pathway operates by the directed
conversion of different subforms and involves the import
of various peroxisomal proteins into distinct intermedi-
ates along the pathway. We also reconstitute in vitro the
fusion of two populations of small peroxisomal vesicles
that represent the earliest intermediates in the assembly
pathway. We provide evidence that the in vitro fusion re-
action reconstructs an actual in vivo peroxisome assembly
 
event that requires the action of the ATPases, Pex1p and
Pex6p.
 
Materials and Methods
 
Strains and Reagents
 
The 
 
Y
 
.
 
 lipolytica
 
 strains used in this study, media, growth conditions, and
genetic techniques have been described (Eitzen et al., 1997; Titorenko et al.,
1997). The specificities of anti-SKL antibodies and antibodies to
 
 
 
acyl-CoA
oxidase (AOX), thiolase (THI; Szilard et al., 1995); isocitrate lyase (ICL),
malate synthase (MLS; Titorenko et al., 1998); Pex2p (Eitzen et al., 1996);
Pex16p (Eitzen et al., 1997); Kar2p and Sec14p (Titorenko et al., 1997)
have been described. Anti-AOX antibodies used in this study specifically
recognize peroxisomal isoform Aox1p (data not presented), one of five
AOXs in 
 
Y
 
.
 
 lipolytica
 
 (Wang et al., 1999). Antibodies to Pex1p and Pex6p,
which were raised against fusions of Pex1p and Pex6p with maltose-bind-
ing protein, specifically recognized 100- and 116-kD polypeptides, respec-
tively, in cell lysates of the wild-type strain but not in lysates of the
 
pex1KO
 
 and 
 
pex6KO
 
 mutant strains (data not presented). The nucleotide
sequence of the 
 
Y
 
.
 
 lipolytica PEX1
 
 gene and the deduced amino acid se-
quence of its encoded protein, Pex1p, have been deposited in the DDBJ/
EMBL/GenBank databases with accession number AF208231. Fab frag-
ments of IgGs were produced using the ImmunoPure Fab Preparation Kit
(Pierce), followed by Fab concentration and buffer exchange (Haas and
Wickner, 1996).
 
Subcellular Fractionation and Peroxisome Isolation
 
Subcellular fractionation of 
 
Y
 
.
 
 lipolytica
 
 cells grown in oleic acid-contain-
ing YPBO medium and isolation of highly purified mature peroxisomes,
P6, were performed as described previously (Titorenko et al., 1998). To
purify different subforms of high-speed pelletable peroxisomes (HSP), a
200,000-
 
g
 
 pellet fraction (200KgP) was subjected to centrifugation on a
discontinuous sucrose (18, 25, 30, 35, 40, and 53%, wt/wt) gradient at
120,000 
 
g
 
 for 18 h at 4
 
8
 
C in a Beckman SW28 rotor. 36 fractions of 1 ml
each were collected. Fractions containing different subforms of HSP were
recovered, and 4 vol of 0.5 M sucrose in buffer H (5 mM MES, pH 5.5, 1 mM
KCl, 0.5 mM EDTA, 0.1% ethanol, and a mixture of protease inhibitors;
Szilard et al., 1995) were added. Peroxisomes were pelleted onto a 150-
 
m
 
l
cushion of 2 M sucrose in buffer H by centrifugation at 200,000 
 
g
 
 for 20
min at 4
 
8
 
C in a Beckman TLA120.2 rotor. Individual pellets of different
subforms of HSP were resuspended in 3 ml of 50% (wt/wt) sucrose in
buffer H.
For purification of HSP subforms P1 and P2, pellets of P1 and P2 resus-
pended in 50% (wt/wt) sucrose in buffer H were overlaid with 30, 28, 26,
24, 22, and 10% sucrose (all wt/wt in buffer H). After centrifugation at
120,000 
 
g
 
 for 18 h at 4
 
8
 
C in a SW28 rotor, 18 fractions of 2 ml each were
collected. P1 and P2 were pelleted, resuspended and subjected to a second
flotation on the same multistep sucrose gradient. Gradients were fraction-
ated into 2-ml fractions as above, and P1 and P2 were recovered and pel-
leted. Pelleted P1 and P2 were resuspended in T99 buffer (15 mM MES,
pH 6.0, 100 mM KCl, 50 mM KOAc, 3 mM MgCl
 
2
 
, 2 mM MgOAc) con-
taining 250 mM sorbitol, and washed twice by resuspension in this buffer
containing sorbitol followed by centrifugation, as described above. P1 and
P2 were ultimately resuspended in T99 buffer plus 250 mM sorbitol and
used in the fusion assay.
For purification of HSP subforms P3 and P4, pellets of P3 and P4 resus-
pended in 50% (wt/wt) sucrose in buffer H were overlaid with 38%, 35%,
33% and 20% sucrose (all wt/wt in buffer H). After centrifugation at
120,000 
 
g
 
 for 18 h at 4
 
8
 
C in a SW28 rotor, 18 fractions of 2 ml each were
collected. P3 and P4 were pelleted, resuspended in 3 ml of 50% (wt/wt) su-
crose in buffer HE (20 mM MES, pH 5.5, 20 mM EDTA, 0.1% ethanol),
overlaid with 39, 37, 35, 33, and 20% sucrose (all wt/wt in buffer HE), and
subjected to centrifugation as above. Gradients were fractionated into
2-ml fractions, and P3 and P4 were recovered and pelleted. After resus-
pension in 3 ml of 50% (wt/wt) sucrose in buffer H, P3 and P4 were again
subjected to flotation on the second multistep sucrose gradient described
above. Gradients were fractionated into 2-ml fractions, and P3 and P4
were recovered and pelleted.
To recover peroxisomes from in vitro fusion reactions, reactions were
placed on ice for 3 min and diluted 10-fold with ice-cold buffer H contain-
ing 250 mM sorbitol. Peroxisomes were pelleted, resuspended in 400 
 
m
 
l of
50% (wt/wt) sucrose in buffer H, overlaid with 30, 28, 26, 24, 22, and 10% 
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sucrose (all wt/wt in buffer H), and subjected to centrifugation at 200,000 
 
g
 
for 18 h at 4
 
8
 
C in a Beckman SW50.1 rotor. 18 fractions of 275 
 
m
 
l each
were collected.
Cytosol for in vitro peroxisome fusion reactions was prepared in T99
buffer containing 250 mM sorbitol, essentially as described (Rexach and
Schekman, 1991).
 
In Vitro Peroxisome Fusion Assay
 
P1 were isolated from unlabeled wild-type, 
 
pex5KO
 
 or 
 
pex16-HA
 
 cells,
while P2 were isolated from 
 
pex5KO
 
 cells labeled with 
 
L
 
-[
 
35
 
S]methionine
for 30 min (Titorenko et al., 1998). The standard peroxisome fusion reac-
tion (40 
 
m
 
l) contained 20 
 
m
 
g of unlabeled P1 and 20 
 
m
 
g of radiolabeled P2
in T99 buffer containing 250 mM sorbitol, 1 mg cytosol/ml, 1 mM ATP,
40 mM creatine phosphate, and 10 U creatine kinase/ml. The nonhydro-
lyzable analogues ATP
 
g
 
S and GTP
 
g
 
S were used at concentrations of 1 mM.
After incubation at 26
 
8
 
C, reactions were placed on ice for 3 min and then
diluted 10-fold with ice-cold D buffer (15 mM MES, pH 6.0, 250 mM sor-
bitol, and a cocktail of protease inhibitors). Peroxisomes were pelleted by
centrifugation at 100,000 
 
g
 
 for 8 min at 4
 
8
 
C in a TLA120.2 rotor, resus-
pended in 400 
 
m
 
l of D buffer, and repelleted. Immunoprecipitation of the
precursor (pTHI) and mature (mTHI) forms of THI was performed under
denaturing conditions (Titorenko et al., 1998) using anti-THI antibodies
covalently coupled to protein A–Sepharose, as described (Xu et al., 1998).
Immunoprecipitates were subjected to a second immunoprecipitation (re-
capture) step (Bonifacino and Dell’Angelica, 1998), resolved by SDS-
PAGE, and visualized by fluorography. Fluorograms were quantitated by
densitometry, and the percentage of conversion of pTHI to mTHI was cal-
culated.
 
Other Methods
 
Pulse–chase experiments were performed as described (Titorenko et al.,
1998). Activities of marker enzymes for peroxisomes, mitochondria, ER,
Golgi, vacuole or plasma membrane were determined by established
methods (Titorenko et al., 1998). Peroxisome lysis with Ti8 buffer (10 mM
Tris-HCl, pH 8.0, 5 mM EDTA, 1 mM PMSF, and leupeptin, pepstatin,
 
and aprotinin each at 1 
 
m
 
g/ml), protein extraction, and protease protec-
tion analysis of purified peroxisomes were performed as described
(Szilard et al., 1995). Phospholipids were extracted from whole peroxi-
somes and quantitated as described (Matsuoka et al., 1995). SDS-PAGE
and immunoblotting using a semi-dry electrophoretic transfer system
were performed as described (Titorenko et al., 1998). Antigen-antibody
complexes were detected by enhanced chemiluminescence (Amersham).
Samples for EM analysis were sedimented at 100,000 
 
g
 
 for 20 min at 4
 
8
 
C in
a Beckman TLS55 rotor onto a bed (25–50 
 
m
 
l) of hardened, low-melting
2.5% NuSieve GTG agarose (FMC) and were further processed as de-
scribed (Eitzen et al., 1997). Silver/gold thin sections through oriented pel-
lets were analyzed.
 
Results
 
Purification and Characterization of Multiple Subforms 
of High-Speed Pelletable Peroxisomes
 
Yeast peroxisomes are usually isolated by isopycnic den-
sity gradient centrifugation of a low-speed (20,000 
 
g
 
) pel-
letable organellar fraction (20KgP; Aitchison et al., 1992).
Recently, we have shown that peroxisomal matrix and
membrane proteins of 
 
Y
 
.
 
 lipolytica
 
 are associated not only
with the 20KgP but also with a high-speed (200,000
 
 g
 
) pel-
letable fraction (200KgP; Titorenko et al., 1998). Analysis
of the in vivo trafficking of peroxisomal proteins has re-
vealed that high-speed pelletable peroxisomes (HSP) are
precursors to mature, low-speed pelletable peroxisomes
(LSP) recovered in the 20KgP (Titorenko et al., 1998). To
purify HSP, we first fractionated the 200KgP by isopycnic
centrifugation on a discontinuous sucrose density gradient.
Four peaks of peroxisomal proteins at densities of 1.18
Figure 1. Separation of sub-
forms of high-speed pel-
letable peroxisomes (HSP).
The 200KgP fraction from the
wild-type strain E122 grown
in YPBO for 9 h was fraction-
ated by isopycnic centrifuga-
tion on a discontinuous su-
crose gradient. Sucrose
density (g/cm3) of fractions
and the percent recovery of
loaded protein and of cata-
lase (CAT) activity in frac-
tions are presented. Frac-
tions were analyzed by
immunoblotting with anti-
bodies to peroxisomal matrix
(MLS, AOX, THI, ICL, and
SKL) and membrane (Pex2p,
Pex16p, Pex1p, and Pex6p)
proteins. Numbers in boxes
and arrows indicate the peak
fractions for different sub-
forms of HSP (P1, P2,
P31P4, and P5). These peak
fractions (10 mg of protein)
were immunodecorated with
anti-THI antibodies. The po-
sitions of the 47-kD precursor
form (pTHI) and of the 45-
kD mature form (mTHI) of
THI are indicated. 
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g/cm
 
3
 
 (fraction 5, P5), 1.14 g/cm
 
3
 
 (fraction 15, P3
 
1
 
P4),
1.11 g/cm
 
3
 
 (fraction 23, P1), and 1.09 g/cm
 
3
 
 (fraction 30,
P2) were recovered (Fig. 1). Catalase activity detected in
fractions 9, 18, and 27, which was 
 
z
 
25–50% of the activity
recovered in the four peak fractions of peroxisomal pro-
teins, may have been the result of preferential leakage of
catalase from peroxisomes during their isolation by sub-
cellular fractionation (Roggenkamp et al., 1975). All per-
Figure 2. Purification of P1
peroxisomes. (A) Fractions
21 to 24 containing P1 peroxi-
somes recovered from the
gradient reported in Fig. 1
were pooled and subjected to
flotation to equilibrium on a
multistep sucrose density gra-
dient as described in Materi-
als and Methods. (B) The
peak fractions containing P1
peroxisomes recovered from
the gradient reported in A
were pooled and brought to
equilibrium by flotation on a
second sucrose density gradi-
ent as described in Materials
and Methods. Fractions in A and B were analyzed for sucrose density (g/cm3); for the percent recoveries of loaded protein and of CAT
(peroxisome), alkaline phosphatase (ALP; vacuole), vanadate-sensitive ATPase (ATP; plasma membrane), NADPH/cytochrome c re-
ductase (CCR; ER) and guanosine diphosphatase (GDP; Golgi) marker enzyme activities; and by immunoblotting to peroxisomal ma-
trix (MLS) and membrane (Pex2p, Pex16p, and Pex1p) proteins and to Kar2p (ER) and Sec14p (Golgi) protein markers. (C) Electron
micrographs of an oriented pellet preparation of purified P1 peroxisomes. Panels show two magnifications of the same micrograph.
Bars, 0.2 mm. 
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oxisomal proteins recovered in peaks P1 (Fig. 2 A), P2
(Fig. 3 A), P3
 
1
 
P4 (Fig. 4 A), and P5 (data not presented)
could float out of the most dense sucrose during centrifu-
gation to equilibrium in sucrose density gradients. Accord-
ingly, these proteins were present in membrane-associated
form rather than in aggregates. Furthermore, matrix pro-
teins recovered in the four peaks were resistant to diges-
tion by external protease, i.e., were present in membrane-
enclosed form (see Fig. 7 for data on P1 and P2). Together
these data demonstrate the existence of multiple subforms
of HSP in 
 
Y
 
.
 
 lipolytica
 
.
HSP subforms were further purified by flotation to equi-
librium on additional sucrose density gradients (see Mate-
rials and Methods). P1 peroxisomes thus purified were es-
sentially free of contamination by plasma membrane and
vacuolar elements and contained 
 
,
 
5 and 2% contamina-
tion by ER and Golgi elements, respectively (Fig. 2, A and
B). EM of purified P1 peroxisomes revealed a homoge-
Figure 3. Purification of P2 peroxi-
somes. (A) Fractions 28–32 contain-
ing P2 peroxisomes recovered from
the gradient reported in Fig. 1 were
pooled and subjected to flotation to
equilibrium on a multistep sucrose
density gradient as described in Ma-
terials and Methods. (B) The peak
fractions containing P2 peroxi-
somes recovered from the gradient
reported in A were pooled and
brought to equilibrium by flotation
on a second sucrose gradient as de-
scribed in Materials and Methods.
Fractions in A and B were analyzed
as described in the legend to Fig. 2.
(C) Electron micrographs of an ori-
ented pellet preparation of purified
P2 peroxisomes. Panels show two
magnifications of the same micro-
graph. Bars, 0.2 mm. 
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nous population of vesicles 87 
 
6 
 
8 nm in diameter (
 
n
 
 
 
5
 
250; Fig. 2 C). Purified P2 peroxisomes contained no de-
tectable ER contamination and 
 
,
 
2% contamination by
Golgi and vacuolar elements (Fig. 3, A and B). EM of pu-
rified P2 peroxisomes showed a uniform population of
vesicles 81 
 
6 
 
11 nm in diameter (
 
n
 
 
 
5 
 
250; Fig. 3 C).
Approximately 20% of total ER markers and 20% of to-
tal Golgi markers recovered during isopycnic centrifuga-
tion of the 200KgP cofractionated with peroxisomes com-
prising peak P3
 
1
 
P4 (data not presented). These ER and
Golgi elements could not be separated from P3
 
1
 
P4 during
flotation to equilibrium on a sucrose density gradient (Fig.
4 A). However, treatment of P3
 
1
 
P4 with EDTA, followed
by flotation on a sucrose density gradient containing
EDTA (see Materials and Methods), led to the separation
of ER and Golgi elements from peroxisomal elements
(Fig. 4 B). Two peroxisomal subforms were recovered, one
(P3) peaking at a density of 1.15 g/cm
 
3
 
 (Fig. 4 B, fraction
Figure 4. Purification of P3 and P4 per-
oxisomes. (A) Fractions 12–16 contain-
ing P31P4 peroxisomes recovered from
the gradient reported in Fig. 1 were
pooled and subjected to flotation to
equilibrium on a multistep sucrose den-
sity gradient without EDTA as described
in Materials and Methods. (B) The peak
fractions containing P31P4 peroxi-
somes recovered from the gradient re-
ported in A were pooled, treated with
EDTA, and brought to equilibrium by
flotation on a multistep sucrose gradient
containing EDTA as described in Mate-
rials and Methods. (C and D) The peak
fractions containing P3 (C) and P4 (D)
peroxisomes recovered from the gradi-
ent reported in B were pooled and
brought to equilibrium by flotation on an
additional multistep sucrose density gra-
dient containing EDTA as described in
Materials and Methods. The fractions in
A to D were analyzed as described in the
legends to Figs. 1 and 2. (E) Electron mi-
crographs of an oriented pellet prepara-
tion of purified P3 peroxisomes. Panels
show two magnifications of the same mi-
crograph. Bar, 0.5 mm. 
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11) and a second (P4) peaking at a density of 1.17 g/cm
 
3
 
(Fig. 4 B, fraction 6). These two subforms represent two
distinct types of HSP rather than arise artefactually in
vitro by EDTA-stimulated fragmentation of a single an-
cestor, because while both P3 and P4 contain MLS, AOX,
THI, Pex2p, and Pex16p, only P4 contains ICL (Fig. 4 B).
The dissociation of two distinct peroxisomal subforms
from specific elements of the ER and Golgi by EDTA has
previously been reported for peroxisome-deficient 
 
pex2
 
mutants (Titorenko et al., 1996). Further purification on
additional equilibrium flotation gradients (see Materials
and Methods) yielded P3 and P4 peroxisomes free of con-
tamination by plasma membrane and vacuolar elements
and containing no more than 4–6% contamination by ER
and Golgi elements (Fig. 4, C and D). EM of purified P3
peroxisomes revealed vesicles 288 
 
6 
 
57 nm in diameter (
 
n
 
 
 
5
 
300; Fig. 4 E).
Quantitative immunoblot analysis of MLS and mea-
surement of the enzymatic activity of CAT were used to
determine the yield and percent recovery of individual
forms of HSP and LSP. Typically, protein recovery from
1 L of wild-type cells grown in oleic acid–containing me-
dium was 0.6 mg for P1, 0.8 mg for P2, 0.6 mg for P3, 0.7
mg for P4, 1.0 mg for P5, and 22.8 mg for mature LSP, P6.
After final purification, the recoveries of individual forms
of HSP were 10–14% that obtained after the first fraction-
ation of the 200KgP by isopycnic centrifugation, as re-
ported in Fig. 1.
Dynamics of Peroxisomal Subforms
The multiple subforms of HSP described above are not
artefactually formed during fractionation. Evidence for
the existence of HSP has come from in vivo studies show-
ing that peroxisomal matrix proteins made in the cytosol
traffic first to HSP and then to LSP (Titorenko et al.,
1998). Therefore, HSP are precursors to LSP. Data pre-
sented in Figs. 1–4 also show that the subforms of HSP are
not artefactually formed by fragmentation of a singular
HSP form during fractionation, as the different subforms
of HSP contain different combinations of peroxisomal
proteins. All subforms contain the matrix proteins MLS
and CAT and the membrane proteins Pex2p and Pex16p.
P1 lacks the matrix proteins THI, AOX, anti-SKL–reactive
proteins, and ICL. P2 lacks ICL and anti-SKL–reactive
proteins, while P3 lacks ICL. In contrast, all these peroxi-
somal proteins are found in mature LSP, P6 (Titorenko
et al., 1998). Pex6p is associated with P2, while Pex1p is
found in P1 and P2, but not in P3, P4, or P5 (Fig. 1). Fur-
thermore, P1 lacks THI, P2 contains mostly the 47-kD pre-
cursor of THI, pTHI, while P3, P4, and P5 accumulate
only the 45-kD mature form of THI, mTHI (Fig. 1). Taken
together, these data suggest two alternative mechanisms
for the formation of LSP from HSP. In the first alterna-
tive, different subforms of HSP are unrelated, and each
subform independently converts to mature peroxisomes
through the import of a particular subset of peroxisomal
proteins. In the second alternative, different subforms of
HSP are related through the ordered conversion of one
subform into another, resulting in an organized assembly
pathway leading to the formation of mature LSP. To dis-
tinguish between these two alternatives, we studied the
trafficking of peroxisomal proteins in vivo by pulse–chase
analysis.
The bulk of pulse-labeled MLS is initially found in the
200KgS (cytosolic) fraction, while small amounts are
found in both P1 and P2 peroxisomes (compare Fig. 5, A
and B). By 5 min, most MLS was chased from the cytosol
to P1 and P2 (Fig. 5, A and B). From P1 and P2, MLS was
chased to the P31P4 peak, and by 30 min this transit was
complete (Fig. 5 B). When P3 and P4 peroxisomes were
separated from each other by treatment with EDTA, MLS
Figure 5. In vivo trafficking of the matrix protein, MLS. Sphero-
plasts of the wild-type strain E122 grown in YPBO for 9 h were
pulse-labeled for 1.5 min with L-[35S]methionine and chased with
unlabeled  L-methionine. Samples were taken at the indicated
times after chase. Spheroplasts were subjected to subcellular
fractionation to yield 20KgP, 200KgP, and 200KgS (cytosol) frac-
tions. The 20KgP (D) and 200KgP (B) fractions were further
fractionated by isopycnic centrifugation on discontinuous sucrose
density gradients. The combined P31P4 peaks from the gradi-
ents reported in (B) were treated with EDTA and subjected to
flotation analysis on sucrose density gradients containing EDTA
to yield individual P3 and P4 peaks (C). MLS was immunoprecip-
itated from the cytosol and from individual fractions, and immu-
noprecipitates were resolved by SDS-PAGE and visualized by
fluorography. Arrows indicate the peak fractions for P1 to P5
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was seen to move from P1 and P2 to P3 (Fig. 5, B and C).
By 20 min, MLS began to move from P3 to P4, and by 40
min this transfer was complete (Fig. 5 C). From P4, MLS
was chased to P5 (Fig. 5 B), and from P5, MLS finally
moved to mature LSP, P6 (Fig. 5, B and D). Together,
these data show that different peroxisomal subforms con-
vert in the direction P1, P2®P3®P4®P5®P6. This was
further supported by an analysis of the in vivo trafficking
of pulse-labeled AOX (Fig. 6 A) and THI (Fig. 6 B). In
contrast to MLS, both AOX and THI initially chased from
the cytosol to P2 only. There was no movement of AOX
or THI from the cytosol to P1. Conversion of peroxisomal
subforms as monitored by the chase of AOX and THI
was in the direction P2®P3®P4®P5®P6. Notably, only
pTHI was present in the cytosol (Fig. 6 C). Proteolytic
maturation of pTHI to mTHI was negligible in P2 (Fig. 6,
B and C). In contrast, pTHI that was chased from P2 to P3
was very quickly processed to mTHI (Fig. 6, B and C).
Development of an In Vitro Peroxisome Fusion Assay
The above data showing that MLS trafficked from the cy-
tosol to both P1 and P2 and then to P3, while AOX and
THI went from the cytosol to P2 alone and then to P3 are
consistent with a scenario in which P3 is formed by fusion
of P1 and P2. To test this hypothesis, we set about devel-
oping an in vitro assay for peroxisome fusion using P1 and
P2. This assay is based on the proteolytic processing of a
precursor form of a matrix protein, THI, to its mature
form. In wild-type Y. lipolytica cells, the 47-kD precursor
form of THI, pTHI, is synthesized in the cytosol and pro-
teolytically processed to a 45-kD mature form, mTHI, af-
ter import into the matrix of HSP (Titorenko et al., 1998).
Due to a defect in intraperoxisomal proteolytic processing,
only pTHI is detected in peroxisomes of the peroxisome
assembly mutant, pex5KO (Szilard et al., 1995). For an in
vitro assay for peroxisome fusion, we mixed various com-
binations of P1 from unlabeled wild-type or pex5KO cells
with P2 from L-[35S]methionine-labeled pex5KO cells con-
taining radiolabeled pTHI, and incubated them at 268C in
the presence or absence of cytosol from unlabeled wild-
type cells, ATP, and an ATP-regenerating system. In the
complete reaction (Fig. 7 A, lanes 1 and 2), up to 60% of
pTHI was converted to mTHI. Several lines of evidence
indicate that this maturation of pTHI was due to the fu-
sion of P1 from wild-type cells with P2 from pex5KO cells,
resulting in interaction of the pTHI-processing prote-
ase (from P1) with labeled pTHI (from P2) within the
same compartment and proteolytic processing of pTHI to
mTHI. First, incubation of P1 and P2 from the pex5KO
strain under complete reaction conditions showed no for-
mation of mTHI (Fig. 7 A, lane 3) because of the defect in
intraperoxisomal proteolytic processing of pTHI observed
for pex5KO peroxisomes. Second, solubilization of lume-
nal contents of P1 from wild-type cells and P2 from
pex5KO cells by addition of detergent, followed by incu-
bation in the absence of cytosol, ATP and an ATP-regen-
erating system, led to complete conversion of pTHI to
mTHI (Fig. 7 A, lane 4). In contrast, no conversion was
detected when P1 and P2 from the pex5KO strain were
solubilized by detergent (Fig. 7 A, lane 5). Third, incuba-
tion of P2 from pex5KO cells in the presence of cytosol,
ATP and an ATP-regenerating system, but in the absence
of P1, showed no formation of mTHI (Fig. 7 A, lane 6).
Therefore, proteolytic maturation of pTHI observed in the
complete reaction was not due to the import of a process-
ing protease into P2 from the cytosol or to breakage of P2
and cleavage of pTHI by cytosolic protease(s) during incu-
bation. Fourth, no formation of mTHI was detected when
cytosol, ATP and an ATP-regenerating system were omit-
ted from the reaction (Fig. 7 A, lane 7). Therefore, pro-
teolytic processing of pTHI in the complete reaction was
not due to breakage of P1 and P2, with subsequent release
of pTHI and the processing protease from broken peroxi-
somes.
Biochemical Requirements of Peroxisome Fusion
In Vitro
Fusion of P1 and P2 in vitro requires cytosol (Fig. 7 B,
compare lanes 1 and 3). Fusion was more efficient with cy-
tosol from oleic acid-grown wild-type cells than with cyto-
sol from glucose-grown cells (Fig. 7 B, compare lanes 1
and 2). Growth of Y. lipolytica in oleic acid–containing
medium, but not in glucose-containing medium, requires
assembly of functional peroxisomes and results in exten-
sive peroxisome proliferation (Titorenko and Rachubin-
ski, 1998). These data suggest that changes in the intra-
cellular levels and/or the activity of cytosolic proteins
required for peroxisome fusion are coordinated with
growth substrate–dependent changes in peroxisome as-
sembly and proliferation. Fusion of P1 and P2 in vitro re-
quires ATP and an ATP-regenerating system (Fig. 7 B,
compare lanes 1 and 4, and lanes 2 and 5). The use of ATP
without an ATP-regenerating system resulted in fusion
not more than 6–9% that observed in the complete reac-
tion, while an ATP-regenerating system without ATP was
unable to promote fusion (data not presented). These data
suggest that fusion requires ATP hydrolysis. Indeed, no
fusion was seen if the nonhydrolyzable analogue ATPgS
Figure 6. In vivo trafficking of the matrix proteins, AOX and
THI. Spheroplasts of the wild-type strain E122 were subjected to
pulse–chase, subcellular fractionation, and immunoprecipitation
with antibodies to AOX (A) and THI (B and C) as described in
the legend to Fig. 5. Immunoprecipitates were resolved by SDS-
PAGE and visualized by fluorography. The positions of the 47-kD
precursor form (pTHI) and of the 45-kD mature form (mTHI) of
THI are indicated. K, pTHI and mTHI immunoprecipitated from
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was used instead of ATP (Fig. 7 B, compare lanes 1 and 6,
and lanes 2 and 7). None of ADP, UTP, GTP, GDP and
CTP was able to promote peroxisome fusion in vitro (data
not presented). Overall peroxisome fusion in vitro was in-
hibited by GTPgS (a nonhydrolyzable analogue of GTP)
in the complete reaction, i.e., in the presence of cytosol
and ATP (Fig. 7 B, compare lanes 1 and 10). Fusion of P1
and P2 in vitro had a lag period of z10 min, was most
rapid during the next 30–40 min, and reached steady state
at levels of 50–60% processing of pTHI to mTHI after 90–
120 min of incubation (Fig. 7 C). Fusion displayed a tem-
perature optimum of 268C and a pH optimum of 6.0 (data
not presented).
Pex1p and Pex6p, NSF-like ATPases of the AAA 
Family, Are Required for Peroxisome Fusion In Vitro
Two AAA family ATPases, Pex1p and Pex6p, are re-
quired for peroxisome assembly in Y. lipolytica (Titorenko
and Rachubinski, 1998). Pex1p and Pex6p have been sug-
gested to be involved in vesicle fusion during peroxisome
assembly in vivo (Acharya et al., 1995; Faber et al., 1998).
In wild-type Y. lipolytica cells, Pex1p was associated with
both P1 and P2, while Pex6p localized to P2 only (Fig. 1).
The P1-associated form of Pex1p and the P2-associated
forms of Pex1p and Pex6p were sensitive to externally
added protease even in the absence of detergent, while the
matrix proteins MLS and THI were degraded by trypsin
only when P1 and P2 were disrupted by detergent (Fig. 7,
D and E). The P1-associated form of Pex1p and the P2-
associated forms of Pex1p and Pex6p were solubilized to a
significant extent by 1 M NaCl or 1 M urea and completely
by 0.1 M Na2CO3 (pH 11; Fig. 7, D and E). Therefore,
Pex1p and Pex6p associate as peripheral membrane pro-
teins with the cytosolic surface of P1 (Pex1p) and P2 (both
proteins).
Overall fusion of P1 and P2 was inhibited by anti-Pex1p
and anti-Pex6p antibodies (Fig. 7 B, lanes 8 and 9, respec-
tively), while neither corresponding preimmune serum nor
antibodies to matrix proteins affected fusion (data not pre-
sented). To avoid potential cross-linking of Pex1p or
Pex6p by antibodies, we tested how monovalent Fab frag-
ments prepared from anti-Pex1p and anti-Pex6p IgGs af-
fected overall peroxisome fusion in vitro. Anti-Pex1p Fab
Figure 7. Requirements for peroxisome fusion in vitro. (A) P1 from unlabeled wild-type (WT) or pex5KO cells was mixed with P2 from
pex5KO cells containing 35S-labeled pTHI. Peroxisomes were incubated for the times indicated with or without cytosol from oleic acid
(YPBO)-grown unlabeled wild-type cells, in the presence or absence of ATP, and with an ATP-regenerating system. Triton X-100 was
added to 0.5% (vol/vol) to some samples. (B) P1 from unlabeled wild-type cells and P2 from pex5KO cells containing 35S-labeled pTHI
were combined and incubated for 90 min with or without cytosol from unlabeled oleic acid (YPBO)- or glucose (YEPD)-grown wild-
type cells, in the presence or absence of ATP, ATPgS, GTPgS, anti-Pex1p (120 mg antibody/ml of reaction), or anti-Pex6p (250 mg anti-
body/ml of reaction), and with an ATP-regenerating system. (C) Aliquots of the complete fusion reaction were incubated at 268C for
the times indicated. Reactions in A–C were processed for immunoprecipitation of pTHI and mTHI, SDS-PAGE and fluorography. (A
and E) For protease protection, P1 and P2 peroxisomes (30 mg of protein) were incubated with the indicated amounts (in mg) of trypsin
in the absence or presence of 1.0% (vol/vol) Triton X-100 for 60 min on ice. Reactions were terminated by addition of TCA. Equal por-
tions of the samples were analyzed by immunoblotting with the antibodies indicated. For organellar subfractionation, P1 and P2 perox-
isomes were treated with one Ti8 buffer, 1 M NaCl, 1 M urea, or 0.1 M Na2CO3 (pH 11). After incubation on ice for 1 h, samples were
separated into supernatant (S) and pellet (P) fractions by centrifugation and subjected to immunoblot analysis with antibodies to Pex1p
(P1 and P2) and Pex6p (P2). (F) Effects of anti-Pex1p and anti-Pex6p Fab fragments on in vitro peroxisome fusion. Fab fragments from
preimmune, anti-Pex1p or anti-Pex6p IgGs were mixed at the indicated concentrations with P1 from wild-type cells and P2 from
pex5KO cells containing 35S-labeled pTHI. Fusion reactions were started by addition of cytosol, ATP and an ATP-regenerating system.
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and anti-Pex6p Fab, but not Fab fragments from the corre-
sponding preimmune sera, inhibited peroxisome fusion
(Fig. 7 F). Therefore, in vitro fusion of P1 and P2 requires
the two AAA ATPases, Pex1p and Pex6p.
In Vitro Fusion of P1 and P2 Peroxisomes Results in 
the Formation of Larger and More Dense
P3 Peroxisomes
In the in vitro fusion assay, the extent of proteolytic pro-
cessing of pTHI to mTHI is directly proportional to the
number of fused peroxisomes and is used to quantitate
peroxisome fusion. To apply independent criteria for per-
oxisome fusion and to test for potential changes in size,
shape and/or morphology of fused peroxisomes, we used
P1 from unlabeled pex16-HA cells and P2 from radiola-
beled pex5KO cells containing 35S-labeled pTHI. Instead
of the wild-type form of the peroxisomal membrane pro-
tein Pex16p, P1 from pex16-HA cells contain Pex16p-HA,
a modified Pex16p containing two copies of the hemagglu-
tinin (HA) epitope at its carboxyl terminus (Eitzen et al.,
1997). P1 from pex16-HA cells and P2 from pex5KO cells
were mixed and incubated in the fusion reaction. Aliquots
were taken 10 min and 90 min after the start of the reac-
tion and subjected to fractionation by flotation on a multi-
step sucrose gradient. For the 0 min time point, aliquots of
P1 and P2 were kept individually on ice and mixed imme-
diately before fractionation. Fractionation of the 0 min
time point revealed that the protein markers of P1 (Pex1p
and Pex16p-HA) and P2 (Pex1p, Pex6p, and pTHI)
floated out of the most dense sucrose and concentrated at
densities of 1.11 g/cm3 and 1.09 g/cm3 for P1 and P2, re-
spectively (Fig. 8 A). Protein markers remained specifi-
cally associated with P1 and P2, and therefore, the integ-
rity of these peroxisomal subforms was not compromised
during flotation. EM of oriented pellet preparations of
peak fractions 8 and 14 revealed homogenous populations
of small electron dense vesicles of average diameters 84 6
10 nm and 88 6 14 nm (n 5 250) for P1 and P2, respec-
tively (Figs. 9 B and 10 D).
Peroxisomes isolated after 10 min of the fusion reaction
were predominantly of density 1.10 g/cm3 and peaked in
fraction 11 (Fig. 8 B). This form was designated P1/P2.
Protein markers of P1 (Pex16p-HA) and P2 (pTHI) were
recovered with the P1/P2 form (Fig. 8 B). No detectable
Pex6p and only minor amounts of Pex1p were recovered
with P1/P2 (compare Fig. 8, A and B), consistent with the
observation that incubation of P1 and P2 in the fusion re-
action results in the release of most Pex1p and Pex6p from
the peroxisomal membrane (Titorenko and Rachubinski,
manuscript in preparation). Only pTHI was recovered
with P1/P2 (Fig. 8 D), demonstrating that the pTHI pro-
cessing protease from P1 and pTHI from P2 were not lo-
calized within the same compartment. These data strongly
suggest that the P1/P2 form represents a complex of
docked, but unfused, P1 and P2 peroxisomes. This was
borne out by EM analysis of P1/P2, which showed cluster-
ing of closely apposed peroxisomal vesicles of average di-
ameter 75–100 nm like that of individual P1 and P2 perox-
isomes (Fig. 9 B).
Two peroxisomal forms were present in the sample
taken after 90 min of incubation. The P1/P2 form was still
present (Figs. 8, C and D, and 9 B), as was a second form
that peaked in fraction 4 and was more dense, 1.14 g/cm3,
than P1, P2 or P1/P2 (Fig. 8 C). This abundant form was
designated P3. P3 accumulated Pex16p-HA (marker of
P1) and THI (marker of P2; Fig. 8 C), which was only in its
mature form, mTHI (Fig. 8 D). Therefore, the P3 form
represents the product of fusion between P1 and P2. EM
revealed that P3 had an average diameter of 269 6 68 nm
Figure 8. Biochemical analysis of in vitro peroxisome fusion. (A–C) P1 and P2 combined on
ice immediately before fractionation (A), or aliquots of a fusion reaction taken after 10 min
(B) or 90 min (C) of incubation at 268C, were subjected to flotation on a multistep sucrose
gradient. Sucrose density (g/cm3) of fractions and the percent recovery of loaded protein
and of CAT activity recovered in fractions, are presented. Equal volumes of fractions were
either analyzed by immunoblotting with anti-Pex1p, anti-Pex6p and anti-HA (12CA5) anti-
bodies, or subjected to immunoprecipitation under denaturing conditions using anti-THI
antibodies followed by SDS-PAGE and fluorography. (D) Equal volumes of fraction 14
from gradient A (P2; 0 min), fraction 11 from gradient B (P1/P2; 10 min), and fractions 11 and 4 from gradient C (P1/P2 and P3, respec-
tively; 90 min) were subjected to immunoprecipitation under denaturing conditions using anti-THI antibodies. Immunoprecipitates
were resolved by SDS-PAGE and visualized by fluorography.Titorenko et al. Peroxisome Assembly In Vitro and In Vivo 39
(n 5 300), roughly two to five times that of P1 or P2 (Figs.
9 B and 10 D). Four morphological types of in vitro
formed P3 peroxisomes, designated P3-1, P3-2, P3-3, and
P3-4, were observed (Fig. 9, C–F, respectively). The differ-
ent types of P3 are discussed in greater detail below.
The buoyant density of P3 is greater than that of P1 or
P2 (Fig. 8, A and C). Therefore, fusion of P1 and P2 yields
a more dense peroxisome rather than an organelle of in-
termediate density. The reason for this remains obscure,
but one can speculate that the buoyant density of any per-
oxisome depends on its size, shape, the total and relative
levels of matrix and membrane proteins, the levels of
(phospho)lipids and the (phospho)lipid/protein ratio. Fu-
sion of P1 and P2 causes a significant change in size of the
resulting organelle (Figs. 9 B and 10 D), while changes in
other parameters are modest (Fig. 10). The cumulative ef-
fect of all these changes could result in higher buoyant
density for P3 compared with P1 and P2.
Control experiments in which P1 and P2 were incubated
individually in the fusion reaction did not show any mor-
phological or biochemical evidence of fusion (data not
presented). Therefore, neither P1 nor P2 is capable of self-
fusion in vitro under conditions that support their inter-
fusion.
Fusion of P1 and P2 Peroxisomes In Vitro Reconstructs 
an Early Step in Peroxisome Assembly In Vivo
We compared the biochemical and morphological proper-
ties of P1, P2, and P3 peroxisomes isolated from YPBO-
grown wild-type cells (in vivo peroxisomes) to those of P1,
P2, and P3 peroxisomes recovered from the in vitro perox-
isome fusion reaction (in vitro peroxisomes). In vivo P1
peroxisomes were isolated from wild-type cells, while in
vitro P1 originated from the pex16-HA strain. These two
forms of P1 were very similar to each other in regards to
buoyant density (1.11 g/cm3 for both forms), size and mor-
phology (Figs. 9, A and B, and 10 D), spectra of matrix
(Fig. 10 A) and membrane (Fig. 10 B) proteins and their
relative distributions (Fig. 10 E), levels of matrix and
Figure 9. EM comparison of in vivo and in vitro peroxisomal subforms. (A, C–F) P1, P2, and P3 peroxisomes were purified from the
200KgP of YPBO-grown wild-type cells (in vivo). (B, C–F) P1, P2, and P3 peroxisomes and the P1/P2 docking complex were purified
from a fusion reaction (in vitro) as presented in Fig. 9. P3-1, P3-2, P3-3, and P3-4 show different morphological types of P3 (see text).
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membrane proteins (Fig. 10 C) and phospholipid/protein
ratios (Fig. 10 F).
In vivo P2 peroxisomes were purified from wild-type
cells, while in vitro P2 were isolated from the pex5KO
strain. The only distinction between these two forms was
the absence of a 67-kD protein (Fig. 10 A, asterisk) in in
vitro P2 peroxisomes. No other significant difference be-
tween in vivo and in vitro forms of P2 was observed in re-
gards to buoyant density (1.09 g/cm3 for both forms), size
and morphology (Figs. 9, A and B, 10 D), spectra (Fig. 10,
A and B), levels (Fig. 10 C) and relative distributions (Fig.
10 E) of matrix and membrane proteins, and phospholipid/
protein ratios (Fig. 10 F).
In vitro P3 peroxisomes represent the product of fusion
between P1 purified from pex16-HA cells and P2 isolated
from pex5KO cells. In vitro P3 peroxisomes recovered
from the fusion reaction after 90 min were very similar to
in vivo P3 peroxisomes isolated from wild-type cells in re-
gards to buoyant density (1.14 g/cm3 for in vitro P3 and
1.15 g/cm3 for in vivo P3), size and morphology (Figs. 9
and 10 D), spectra of matrix (Fig. 10 A) and membrane
(Fig. 10 B) proteins and their relative distributions (Fig. 10
E), levels of matrix and membrane proteins (Fig. 10 C),
and phospholipid/protein ratios (Fig. 10 F). In contrast to
P2 peroxisomes accumulating mostly (in vivo P2) or only
(in vitro P2) pTHI, both the in vivo and in vitro forms of
P3 contained exclusively mTHI (Fig. 10 C).
Similar to in vivo P3 purified from wild-type cells, P3
peroxisomes recovered from the in vitro fusion reaction
after 90 min were present in four morphologically distinct
forms (Fig. 9, C–F). P3-1 appeared as densely staining ves-
icles, while P3-2 vesicles contained electron-dense material
only at their periphery. In P3-3 vesicles, densely staining
material was found associated with only some regions of
the membrane. In contrast, P3-4 vesicles, which were the
most abundant form (Table I, T 5 90 min) lacked any in-
ternal, densely staining material. None of the four P3 types
formed in vitro represents a contaminant, since they were
not observed in the preparations of P1 and P2 used for the
in vitro fusion reaction (Fig. 9 B). Therefore, the different
types of P3 peroxisomes formed in vitro represent the
products of fusion of P1 and P2. Importantly, the four
morphological types of P3 peroxisomes could also be puri-
fied from wild-type cells (Fig. 9, C–F, in vivo) in about the
Figure 10. Comparison of P1, P2, and P3 peroxisomes isolated from YPBO-grown wild-type cells (in vivo) or recovered from the in
vitro fusion reaction (in vitro). The spectra of peroxisomal matrix (A) and membrane (B) proteins and their relative distributions (E),
the levels of individual peroxisomal proteins (C), the size (D) and phospholipid/protein ratios (F) of in vivo and in vitro P1, P2, and P3
peroxisomes are presented. (A, B, and E) Purified peroxisomal forms (30 mg of protein) were lysed with Ti8 buffer and subjected to
centrifugation to yield supernatant (matrix proteins) and pellet (membrane proteins) fractions. Recovered proteins were resolved by
SDS-PAGE and stained with Coomassie Blue (A and B) or quantitated with a protein assay kit (E). The numbers at left in A and B in-
dicate the migrations of molecular mass standards (in kD). (C) Equal quantities of protein from P1, P2, and P3 were analyzed by immu-
noblotting with antibodies to the proteins indicated. (D) Oriented pellet preparations of P1, P2, and P3 were fixed and processed for
EM. The diameters of 250 (P1 and P2) or 300 (P3) structures were measured. (F) Phospholipid was extracted from P1, P2, and P3 and
quantitated as described in Materials and Methods.Titorenko et al. Peroxisome Assembly In Vitro and In Vivo 41
same distributions as their in vitro counterparts (Table I,
compare in vivo to in vitro, T 5 90 min). Why there are
four distinguishable types of P3 peroxisomes remains ob-
scure. Interestingly, P3 peroxisomes recovered from the in
vitro fusion reaction after 10 min contained only 10% as
the P3-4 form, while at 90 min z50% of P3 peroxisomes
were of the P3-4 form, similar to the levels found in the in
vivo situation (Table I). Based on these data, one could
speculate that P3-1, P3-2, P3-3, and P3-4 represent consec-
utive stages in a post-fusion reorganization of P3 peroxi-
somes that occurs both in vivo and in vitro.
Taken together, the above data provide evidence that
the in vitro fusion of P1 and P2 to yield P3 reconstructs an
actual in vivo peroxisome assembly event involving the fu-
sion of distinct small peroxisomal vesicles to form a larger
and more dense peroxisomal vesicle.
Discussion
Peroxisome Assembly Pathway
We have previously demonstrated that, based on sedimen-
tation properties, peroxisomes of Y. lipolytica belong to
two groups, HSP and LSP (Titorenko et al., 1998). In vivo
pulse–chase labeling revealed that HSP are precursors to
mature LSP peroxisomes (Titorenko et al., 1998). Here,
we report the purification of five distinct forms of HSP,
designated P1 to P5. LSP are designated P6. In vivo pulse–
chase labeling showed that MLS is imported directly from
the cytosol with equal efficiency into the matrix of P1 or
P2 peroxisomes. In contrast, MLS is not imported into P3,
P4, P5, or P6. Therefore, P1 and P2 are import-competent
for MLS, while the other peroxisomal subforms are not. In
contrast, P2 peroxisomes import two other matrix pro-
teins, AOX and THI, directly from the cytosol, while the
other five subforms fail to import these proteins. Our ki-
netic data on the selective import competencies of distinct
peroxisomal subforms are consistent with observed differ-
ences in the spectra of matrix and membrane proteins as-
sociated with each of the subforms (see Figs. 1–4). Taken
together, our data demonstrate that the subforms of HSP
differ in their import competencies for various peroxiso-
mal proteins.
Data on the in vivo dynamics of peroxisomal protein lo-
calization to distinct HSP subforms show that these sub-
forms are organized into a multistep peroxisome assembly
pathway. The pathway operates by conversion of subforms
in the direction P1, P2®P3®P4®P5®P6 and involves the
import of various peroxisomal proteins into distinct inter-
mediates along the pathway. Several lines of evidence sup-
port the physiological basis of this peroxisome assembly
pathway. First, as we have presented here, multiple perox-
isomal subforms isolated from wild-type cells are not arte-
factually formed in vitro by fragmentation of LSP or of a
singular HSP ancestor during the fractionation procedure.
Second, treatment of spheroplasts with sodium azide dur-
ing pulse–chase experiments is unlikely to cause the for-
mation of (aberrant) peroxisomal forms, as these same
forms can be isolated by subcellular fractionation of wild-
type cells not treated with azide. Moreover, at different
times of chase, pulse-labeled MLS, AOX and THI were
localized to different peroxisomal subforms, despite all
spheroplasts being treated identically before and after
chase (including treatment with azide). Third, the specific
order of conversion of different peroxisomal subforms and
their selective import competencies have been demon-
strated in pulse–chase labeling experiments in vivo using
wild-type cells. Fourth, immunofluorescence microscopy
has revealed that not .1–2% of all peroxisomes in wild-
type cells can be decorated with anti-MLS antibodies,
which is a marker protein of all six peroxisomal subforms,
but not with anti-SKL antibodies, which is a marker protein
of all peroxisomal subforms except P1 and P2 (Titorenko
et al., 1998). This low abundance of the two earliest per-
oxisomal precursors, P1 and P2, is in good agreement with
data on the yields of individual forms of HSP and LSP dur-
ing their purification (see Results).
In the present study we have applied several approaches
to provide the first comprehensive experimental evidence
for the existence of a multistep peroxisome assembly path-
way. Similar pathways have recently been proposed in sev-
eral models of peroxisome assembly (Subramani, 1996;
Erdmann et al., 1997; South and Gould, 1999). These mod-
els have been inspired by early data on the heterogeneity
of peroxisomes (Heinemann and Just, 1992; Lüers et al.,
1993; van Roermund et al., 1995; Wilcke et al., 1995; van
der Klei and Veenhuis, 1996), as well as by recent data
suggesting a sequential import of membrane and matrix
proteins into defined peroxisomal precursors (South and
Gould, 1999).
Peroxisome Fusion In Vitro
We have developed an in vitro assay for the fusion of the
early peroxisomal subforms, P1 and P2. Fusion of P1 and
P2 in vitro was monitored by the extent of proteolytic pro-
cessing of pTHI to mTHI and was confirmed by purifica-
tion and EM analysis of docked P1 and P2 and of the P3
form resulting from their fusion.
Homotypic, or self-fusion, is operationally defined as
the fusion of vesicles derived from a single organelle, while
heterotypic fusion involves fusion between vesicles de-
rived from different organelles (Denesvre and Malhotra,
1996). Homotypic fusion involves identical membranes,
while heterotypic fusion occurs between vesicles of dif-
ferent protein composition (Mellman, 1995). Recently,
yeast vacuoles have been shown to undergo pseudohetero-
Table I. Percentage of Different Morphological Types of
P3 Peroxisomes
Morphological 
type
% 6 SD
In vitro
In vivo T 5 10 min T 5 90 min
P3-1 16 6 4 26 6 3 13 6 2
P3-2 15 6 1 35 6 4 17 6 3
P3-3 19 6 4 28 6 3 15 6 3
P3-4 50 6 8 11 6 4 55 6 4
P3 peroxisomes were isolated from YPBO-grown wild-type cells (in vivo) or
recovered from the in vitro fusion reaction (in vitro) at 10 and 90 min. Organelles were
fixed and processed for EM. Oriented pellet preparations were analyzed. For definition
of the morphological types of P3, see text. 300 structures in each of the in vivo and in
vitro preparations of P3 were examined.The Journal of Cell Biology, Volume 148, 2000 42
typic fusion in vitro between those vacuoles with only
t-SNAREs and those with only v-SNAREs (Ungermann
et al., 1998). Despite the fact that in vitro fusion between
P1 and P2 involves vesicles from the same compartment
type (peroxisome), the protein compositions of the fusion
partners are dissimilar (see Figs. 1 and 10). Moreover, nei-
ther P1 nor P2 is able to self-fuse in vitro under conditions
that support their inter-fusion. Therefore, fusion between
P1 and P2 is pseudoheterotypic.
In vitro fusion of P1 and P2 is driven by ATP hydrolysis
and requires cytosolic proteins. The intracellular levels
and/or the fusogenic activity of these cytosolic proteins are
dramatically induced under growth conditions that stimu-
late extensive peroxisome proliferation. Furthermore, our
observation that GTPgS (a nonhydrolyzable analogue of
GTP) inhibits peroxisome fusion in vitro suggests the in-
volvement of a Ras-like (Novick and Zerial, 1997) and/or
Fzo-like (Hermann and Shaw, 1998) GTPase(s) in the fu-
sion of P1 and P2. In vitro fusion of P1 and P2 also re-
quires Pex1p and Pex6p, two ATPases of the AAA pro-
tein family. Organelle biogenesis–associated members of
this family contain two AAA cassettes each with an ATP-
binding site and are required for all known homotypic and
heterotypic membrane fusion reactions (Patel and Latter-
ich, 1998). Our data demonstrate the essential role of
Pex1p and Pex6p in the fusion of peroxisomal vesicular
structures, which has previously been suggested (Acharya
et al., 1995; Faber et al., 1998). Importantly, peroxisome
fusion requires two AAA ATPases, similar to the fusion
of drug-induced and postmitotic Golgi fragments which is
mediated by two other ATPases of the AAA protein fam-
ily, NSF and p97/VCP (Acharya et al., 1995; Rabouille et al.,
1995). In contrast, vacuole fusion (Haas and Wickner,
1996) and fusion of ER membranes (Latterich et al., 1995)
in yeast require only one AAA ATPase, Sec18p (NSF), or
Cdc48p (p97/VCP), respectively.
The development of an in vitro assay provides a valu-
able experimental tool for the identification of other
components that may be involved in peroxisome fusion,
e.g., SNAPs, SNAREs, Ras-, and/or Fzo-like GTPases,
and for the elucidation of their roles in the fusion pro-
cess.
Fusion of P1 and P2 In Vitro Reconstructs an Actual In 
Vivo Peroxisome Assembly Event
Pulse–chase analysis of the in vivo trafficking of peroxiso-
mal matrix proteins revealed that peroxisomal subform P3
is formed from two earlier subforms, P1 and P2. The re-
sults of experiments presented herein support our conten-
tion that the in vitro fusion of P1 and P2 to form P3 perox-
isomes is a valid reconstruction of an actual biogenetic
event involving these subforms during peroxisome assem-
bly in Y. lipolytica. First, in vivo P3 peroxisomes isolated
from wild-type cells and P3 peroxisomes formed in vitro
from the fusion of P1 and P2 peroxisomes contain exclu-
sively mTHI, while P2 peroxisomes accumulate primarily
(in vivo) or only (in vitro) pTHI. Second, in vivo P3 iso-
lated from wild-type cells and in vitro P3 peroxisomes re-
covered from the in vitro fusion reaction are made up of
the same four types of vesicular peroxisomal structures. In
addition, the percentages of these four types of peroxiso-
mal structures are very similar in the in vivo and in vitro
preparations of P3 (Table I, T 5 90 min). Third, in vivo
and in vitro P3 peroxisomes are very similar according to a
number of biochemical criteria including density, matrix
and membrane protein spectra and levels, and phospho-
lipid/protein ratio.
That the in vitro fusion of P1 and P2 peroxisomes to
make P3 peroxisomes reconstructs an actual early step in
peroxisome assembly in vivo is also supported by the fact
that the in vitro fusion assay reproduces some genetic re-
quirements of peroxisome biogenesis in vivo. Fusion in
vitro requires Pex1p and Pex6p. In vivo, defects in these
AAA ATPases affect peroxisome assembly in yeast (Erd-
mann et al., 1991; Spong and Subramani, 1993; Heyman et
al., 1994; Titorenko and Rachubinski, 1998) and in humans
(Geisbrecht et al., 1998). Moreover, while inactivation of
Pex1p and Pex6p with antibodies affects peroxisome fu-
sion in vitro and prevents formation of the comparatively
large (z270 nm) P3 from their smaller (z90 nm) P1 and
P2 precursors, pex1 and pex6 mutations in vivo prevent
the formation of normal peroxisomes and cause the accu-
mulation of small peroxisomal vesicles (Spong and Subra-
mani, 1993; Heyman et al., 1994; Titorenko and Rachubin-
ski, 1998), suggesting a defect in vesicle fusion during
peroxisome assembly (Acharya et al., 1995; Faber et al.,
1998). Notably, Pex1p and Pex6p have been suggested to
form a complex of central importance to peroxisome bio-
genesis, as disruption of their interaction has been shown
to be the most common cause of the peroxisomal biogene-
sis disorders Zellweger syndrome, neonatal adrenoleuko-
dystrophy, and infantile Refsum disease (Geisbrecht et al.,
1998). It should be noted that the role of Pex1p and Pex6p
in peroxisome fusion, which has been directly demon-
strated in this study and has been suggested by other inves-
tigations (Acharya et al., 1995; Erdmann et al., 1997; Faber
et al., 1998), is not the only function proposed for these
two AAA ATPases. In human cells, Pex1p and Pex6p may
also play a role in the stability of Pex5p, the receptor for
matrix proteins targeted by peroxisomal targeting signal-1
(Geisbrecht et al., 1998). However, it remains unclear
whether the role played by Pex1p and Pex6p in the stabil-
ity of Pex5p is direct or indirect. The stability and abun-
dance of Pex5p were not decreased in pex1 and pex6 mu-
tants of P. pastoris (Spong and Subramani, 1993; Heyman
et al., 1994; Faber et al., 1998) and Y. lipolytica (our un-
published data). For both yeast species, no interaction be-
tween Pex1p and Pex5p or between Pex6p and Pex5p has
been revealed by yeast two-hybrid analysis (Faber et al.,
1998; our unpublished data).
In conclusion, we have demonstrated the existence of a
multistep peroxisome assembly pathway in the yeast Y. li-
polytica. We have also established an in vitro assay that re-
constitutes the fusion of two early peroxisomal precursors,
and have shown that this in vitro fusion reconstructs an ac-
tual early step in peroxisome assembly in vivo. This study
provides valuable experimental tools for the identification
of other components involved in peroxisome fusion or that
are required for the conversion of intermediates of the
peroxisome assembly pathway. The identification of such
components would not only provide greater insight into
the general mechanisms regulating peroxisome assembly
in vivo, but would also enhance our understanding of theTitorenko et al. Peroxisome Assembly In Vitro and In Vivo 43
molecular defects underlying the peroxisome biogenesis
disorders.
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